| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JCB.24964 |
| P698 | PubMed publication ID | 25187114 |
| P50 | author | Bin Huang | Q60311397 |
| P2093 | author name string | Yoe-Sik Bae | |
| Soo Jung Lee | |||
| Suk-Hwan Baek | |||
| Ji Hyo Lyu | |||
| Su Hwan Kang | |||
| Jin-Gu Lee | |||
| Dae-Weon Park | |||
| Chuhee Lee | |||
| P2860 | cites work | RGS16 inhibits breast cancer cell growth by mitigating phosphatidylinositol 3-kinase signaling | Q37372117 |
| Regulator of G-protein signaling (RGS) proteins in cancer biology | Q37533157 | ||
| Deubiquitinases in cancer: new functions and therapeutic options. | Q37945451 | ||
| mRNA degradation by the endoribonuclease Regnase-1/ZC3H12a/MCPIP-1 | Q38090260 | ||
| Regulator of G Protein Signaling 6 Mediates Doxorubicin-Induced ATM and p53 Activation by a Reactive Oxygen Species–Dependent Mechanism | Q38748068 | ||
| Role of JAK2–STAT3 in TLR2‐mediated tissue factor expression | Q39226459 | ||
| RGS2 is a negative regulator of STAT3-mediated Nox1 expression | Q39436714 | ||
| Regulatory feedback loop between NF-kappaB and MCP-1-induced protein 1 RNase | Q39800740 | ||
| RGS4 is arginylated and degraded by the N-end rule pathway in vitro | Q41732590 | ||
| Regulator of G protein signaling 2 is a key modulator of airway hyperresponsiveness | Q54503971 | ||
| Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure | Q24299443 | ||
| A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages | Q24305522 | ||
| TSPYL5 suppresses p53 levels and function by physical interaction with USP7 | Q24317937 | ||
| Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer | Q24644185 | ||
| MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer | Q24651422 | ||
| The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits | Q24810130 | ||
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction | Q28116119 | ||
| N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells | Q28283150 | ||
| Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay | Q28588318 | ||
| RGS expression in cancer: oncomining the cancer microarray data | Q30596824 | ||
| PPSP: prediction of PK-specific phosphorylation site with Bayesian decision theory | Q33237091 | ||
| Genome-wide survey and expression profiling of CCCH-zinc finger family reveals a functional module in macrophage activation | Q33358022 | ||
| Transcription factors Elk-1 and SRF are engaged in IL1-dependent regulation of ZC3H12A expression | Q33529882 | ||
| Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1. | Q33873408 | ||
| RGS4 and RGS5 are in vivo substrates of the N-end rule pathway | Q34085136 | ||
| RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy | Q34108087 | ||
| Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice | Q34177503 | ||
| MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-kappaB signaling | Q34420804 | ||
| Regulator of G protein signaling 6 (RGS6) induces apoptosis via a mitochondrial-dependent pathway not involving its GTPase-activating protein activity. | Q34489034 | ||
| Phosphorylation of RGS13 by the Cyclic AMP-dependent Protein Kinase Inhibits RGS13 Degradation | Q34541388 | ||
| Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk | Q34624142 | ||
| Targeted disruption of MCPIP1/Zc3h12a results in fatal inflammatory disease | Q34659842 | ||
| Alternative ubiquitin activation/conjugation cascades interact with N-end rule ubiquitin ligases to control degradation of RGS proteins. | Q35151521 | ||
| Epigenetic repression of regulator of G‐protein signaling 2 promotes androgen‐independent prostate cancer cell growth | Q35163061 | ||
| Cardiotonic steroids stabilize regulator of G protein signaling 2 protein levels | Q36174768 | ||
| Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers | Q36465333 | ||
| Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance. | Q36589865 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 260-267 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Journal of Cellular Biochemistry | Q6294917 |
| P1476 | title | RGS2 suppresses breast cancer cell growth via a MCPIP1-dependent pathway | |
| P478 | volume | 116 |
| Q59327071 | Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression |
| Q89589684 | Combined Use of Three Machine Learning Modeling Methods to Develop a Ten-Gene Signature for the Diagnosis of Ventilator-Associated Pneumonia |
| Q104073663 | Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma |
| Q49387003 | Downregulation of regulator of G protein signaling 2 expression in breast invasive carcinoma of no special type: Clinicopathological associations and prognostic relevance |
| Q38720601 | Epigenetic regulation of RGS2 (Regulator of G-protein signaling 2) in chemoresistant ovarian cancer cells |
| Q30176404 | FBXO44-Mediated Degradation of RGS2 Protein Uniquely Depends on a Cullin 4B/DDB1 Complex. |
| Q37407194 | Gene expression profiling of the 8q22-24 position in human breast cancer: TSPYL5, MTDH, ATAD2 and CCNE2 genes are implicated in oncogenesis, while WISP1 and EXT1 genes may predict a risk of metastasis |
| Q36562247 | Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance |
| Q35202285 | Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia |
| Q36693265 | MCPIP1 Selectively Destabilizes Transcripts Associated with an Antiapoptotic Gene Expression Program in Breast Cancer Cells That Can Elicit Complete Tumor Regression |
| Q98386353 | Mechanistic studies of cytotoxic activity of the mesoionic compound MIH 2.4Bl in MCF-7 breast cancer cells |
| Q38840679 | Monocyte Chemoattractant Protein-Induced Protein 1 Overexpression Modulates Transcriptome, Including MicroRNA, in Human Neuroblastoma Cells. |
| Q59125738 | RGS17 inhibits tumorigenesis and improves 5-fluorouracil sensitivity in nasopharyngeal carcinoma |
| Q33652118 | Regnase-1, a rapid response ribonuclease regulating inflammation and stress responses |
| Q47637709 | Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins |
| Q33903831 | Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets |
| Q41471015 | Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth. |
| Q30397640 | The evolution of regulators of G protein signalling proteins as drug targets - 20 years in the making: IUPHAR Review 21. |
Search more.